COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Subscribe now to continue reading.

The US administered another 1.5 million doses on Saturday - a total of 20.5 million doses have now been administered in the country. Over 63 million doses have been administered globally and more than 55 countries have now launched national immunisation programs. Pfizer and AstraZeneca have reduced the number of vaccines doses expected to be delivered to the European Union in the first quarter of 2021. …

Subscribe now to continue reading.

COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Latest Video

Most Read

The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants

Potential merger could create a new global oncology powerhouse

First new brain cancer treatment listed on PBS after more than 20 years

The risk to patients is that new pricing policies could swamp any benefit from the HTA Review

Arrotex Pharmaceuticals appoints experienced industry executive as CMO

New Stories

Pharmac announces plan to revise its recently expanded patient advisory function

Australian company announces agreement with Lilly to trial lung cancer combination

The complete absence of patient power and agency makes this a health system outlier

Arrotex Pharmaceuticals appoints experienced industry executive as CMO

The risk to patients is that new pricing policies could swamp any benefit from the HTA Review

Potential merger could create a new global oncology powerhouse

The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants

Sign In

COVID-19 vaccine manufacturing, supply and administration programs

This is a preview of subscriber content

Latest Video

Most Read

The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants

Potential merger could create a new global oncology powerhouse

First new brain cancer treatment listed on PBS after more than 20 years

The risk to patients is that new pricing policies could swamp any benefit from the HTA Review

Arrotex Pharmaceuticals appoints experienced industry executive as CMO

Follow Us

New Stories

Pharmac announces plan to revise its recently expanded patient advisory function

Australian company announces agreement with Lilly to trial lung cancer combination

The complete absence of patient power and agency makes this a health system outlier

Arrotex Pharmaceuticals appoints experienced industry executive as CMO

The risk to patients is that new pricing policies could swamp any benefit from the HTA Review

Potential merger could create a new global oncology powerhouse

The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants